Salivary cortisol measurement provides a non-invasive method to assess HPA axis function in cannabis patients, particularly relevant given emerging evidence that chronic cannabis use may affect cortisol patterns. Improved collection and analysis protocols could enhance our ability to monitor stress response in patients using cannabis therapeutically for anxiety, PTSD, or chronic pain conditions.
This webinar addresses technical aspects of salivary cortisol collection and analysis, focusing on standardization of methodology from sample collection through laboratory confidence intervals. Salivary cortisol reflects free, bioactive hormone levels and offers advantages over serum collection for stress research and clinical monitoring. The timing of collection, patient preparation, and analytical validation remain critical factors affecting result reliability and clinical interpretation.
“While I don’t routinely order salivary cortisol in cannabis patients, understanding stress biomarkers becomes increasingly relevant as we recognize cannabis’s complex effects on the HPA axis. Better standardization of these assays could help us distinguish therapeutic stress relief from potentially problematic cortisol suppression.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
What is the HPA axis and why is it important?
The HPA axis (hypothalamic-pituitary-adrenal axis) is a complex system that regulates the body’s stress response. It controls the release of cortisol, a key stress hormone that affects metabolism, immune function, and various physiological processes.
How does cortisol function as a biomarker?
Cortisol levels serve as a measurable indicator of stress and HPA axis function in the body. Abnormal cortisol patterns can signal various health conditions, including stress disorders, adrenal dysfunction, and mental health issues.
What does this clinical relevance rating mean?
The CED Clinical Relevance #70 rating indicates this is a finding of “Notable Clinical Interest.” This means the research presents emerging findings or policy developments that healthcare providers should monitor closely for potential clinical applications.
How might cannabis affect stress response systems?
Cannabis compounds may interact with the body’s stress response mechanisms, potentially influencing cortisol production and HPA axis function. Research is ongoing to understand these interactions and their therapeutic implications for stress-related conditions.
Why are biomarkers important in cannabis research?
Biomarkers like cortisol provide objective, measurable indicators of how cannabis affects physiological systems. They help researchers and clinicians assess therapeutic effects, monitor treatment responses, and understand the biological mechanisms of cannabis-based interventions.